//Your Connection to the Life Sciences Industry
Connect to IBC:LinkedIn iconTwitter iconFacebook iconBlog iconRSS icon


Online Registration is Closed
Read more details on how to register on-site. Call 800-390-4078 or email reg@ibcusa.com for more information.
»Pricing Chart

Download Brochure

Add to Outlook Calendar

Find Another IBC Event

TIDES: Oligonucleotide and Peptide Therapeutics


Agenda CSS

May 09-12, 2016
Long Beach Convention & Entertainment Center
Long Beach, CA

Alt Language

Alternative Language Options:

  • Japanese
  • Korean
  • Taiwanese
  • Chinese

Event Overview

Event Overview

The industry's #1 forum for oligonucleotide and peptide leaders to build successful partnerships and accelerate products from early discovery through late-stage development and commercialization

Visionary Experts Provide Key Success Factors for Drug Development and Manufacturing

Richard DiMarchi

Mixed-Incretin Receptor Biochemical Signaling at Multiple Receptors Richard DiMarchi
Standiford H. Cox Professor of Chemistry
Indiana University

Robert Baffi, Ph.D.

Drisapersen: Case Study Robert Baffi, Ph.D.
Executive VP, Technical Operations
BioMarin Pharmaceutical

Danny Zurr, Ph.D.

Quark's Long History of Oligonucleotide Development Danny Zurr, Ph.D.
Chairman and Chief Executive Officer
Quark Pharmaceuticals Inc.

John Reed, M.D., Ph.D.

Technologies for Targeting Molecules to Sites of Disease John Reed, M.D., Ph.D.
Global Head
Roche Pharma Research and Early Development, Switzerland

Learn More

Get Your Approval to Attend Today so You Can Participate in the Following Ways

  • Present a poster and share your own research
  • Evaluate technologies and services from over 70 exhibitors
  • Network with over 800 fellow attendees using the new partnering tool
  • Meet over 100 renowned speaker experts in oligo and peptide discovery, preclinical, clinical and chemistry, manufacturing and controls

Register Now

"We started attending TIDES five years ago on the recommendation of an oligo therapeutics client. We find that this venue offers unique access to 'C' level scientists from around the globe and the lectures are… first-rate" - Tom Falzareno, Tandem Labs